What is protein A resin used for?

Protein A resin is primarily used for the purification of monoclonal antibodies in biopharmaceutical production, leveraging its specific binding properties to isolate antibodies from complex mixtures.

How big is the Protein A Resin Market?

The global Protein A Resin Market size was estimated at USD 1.3 Billion in 2023 and is expected to reach USD 3.0 Billion in 2033.

What is the Protein A Resin Market growth?

The global Protein A Resin Market is expected to grow at a compound annual growth rate of 8.7 From 2024 To 2033

Who are the key companies/players in the Protein A Resin Market?

Some of the key players in the Protein A Resin Markets are Thermo Fisher Scientific Inc., Repligen Corp., PerkinElmer, Inc., Novasep Holdings SAS, Navigo Proteins GmbH, Merck Millipore, GenScript Biotech Corp., GE Healthcare, Bio-Rad Laboratories, Inc., Agilent Technologies, and Abcam PLC.

Which regions are leading in the Protein A Resin market?

North America led the market by securing a market share of 41.3%% in 2023.

What factors are driving the growth of the protein A resin market?

The market growth is driven by the increasing demand for monoclonal antibodies, advancements in resin technologies, and the expansion of the biopharmaceutical industry.

How is technology impacting the protein A resin market?

Technological advancements, such as high-capacity and reusable resins, are improving purification processes, enhancing efficiency, and reducing costs, driving market growth.

What role does the biopharmaceutical industry play in the protein A resin market?

The biopharmaceutical industry is the primary driver of the protein A resin market, with increased production of monoclonal antibodies and biologics boosting demand for high-quality purification solutions.

Global Protein A Resin Market By Product Type (Agarose-based, Organic Polymer-based, and Glass/Silica-based), By Type (Recombinant Protein A and Natural Protein A), By Application (Antibody Purification and Immunoprecipitation), By End-user (Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Clinical Research Laboratories), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Aug 2024
Report ID: 125489
Number of Pages: 318
Format:

- Thermo Fisher Scientific Company Profile
- Repligen Corp.
- PerkinElmer, Inc.
- Novasep Holdings SAS
- Navigo Proteins GmbH
- Merck Millipore
- GenScript Biotech Corp.
- GE Healthcare
- Bio-Rad Laboratories, Inc. Company Profile
- Agilent Technologies Inc. Company Profile
- Abcam PLC.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 125489
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (60)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)